Preview Mode Links will not work in preview mode

Apr 22, 2021

Featuring slide presentations and related discussion from Drs Matthew S Davids and Jennifer Woyach, including the following topics:

  • Recent Advances with BTK Inhibitors in the Treatment of CLL — Matthew S Davids, MD, MMSc (0:00)
  • Bcl-2 Inhibitors, PI3K Inhibitors and CAR T-Cell Regimens — Jennifer Woyach, MD...


Apr 22, 2021

Featuring perspectives from Drs Matthew S Davids and Jennifer Woyach on the following topics:

  • Introduction (0:00)
  • Recent advances with BTK inhibitors in the treatment of chronic lymphocytic leukemia (CLL) (1:03)
  • Role of Bcl-2 inhibitor-based regimens in therapy for CLL (42:59)
  • Novel strategies – U2 regimen...


Apr 21, 2021

Proceedings from part 4 of a 4-part webinar series. Featuring perspectives from Drs Paul M Barr, Matthew S Davids and Kerry Rogers, including the following topics:

  • Introduction (0:00)
  • Available and emerging data with Bruton tyrosine kinase inhibitors for chronic lymphocytic leukemia (CLL) (0:53)
  • Role of Bcl-2...


Apr 20, 2021

Featuring slide presentations and related discussion from Drs Arjun Balar, Elisabeth I Heath and Jonathan E Rosenberg, including the following topics:

  • Evolving Management of Nonmetastatic Urothelial Bladder Cancer — Arjun Balar, MD (0:00)
  • Emerging Data for Treatment of Metastatic Urothelial Carcinoma — Jonathan E...


Apr 20, 2021

Featuring perspectives from Drs Arjun Balar, Elisabeth I Heath and Jonathan E Rosenberg on the following topics:

  • Introduction (0:00)
  • Case: A woman in her early 60s with Stage IIIA urothelial bladder cancer (UBC) (4:27)
  • Case: A woman in her late 60s with cisplatin-ineligible muscle-invasive UBC (8:45)
  • Case: A woman in...